コンテンツへスキップ
Merck
  • Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.

Tumour-suppressive microRNA-24-1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer.

FEBS letters (2014-07-08)
Satoru Inoguchi, Naohiko Seki, Takeshi Chiyomaru, Tomoaki Ishihara, Ryosuke Matsushita, Hiroko Mataki, Toshihiko Itesako, Shuichi Tatarano, Hirofumi Yoshino, Yusuke Goto, Rika Nishikawa, Masayuki Nakagawa, Hideki Enokida
要旨

Here, we found that microRNA-24-1 (miR-24-1) is significantly reduced in bladder cancer (BC) tissues, suggesting that it functions as a tumour suppressor. Restoration of mature miR-24-1 inhibits cancer cell proliferation and induces apoptosis. Forkhead box protein M1 (FOXM1) is a direct target gene of miR-24-1, as shown by genome-wide gene expression analysis and luciferase reporter assay. Overexpressed FOXM1 is confirmed in BC clinical specimens, and silencing of FOXM1 induces apoptosis in cancer cell lines. Our data demonstrate that the miR-24-1-FOXM1 axis contributes to cancer cell proliferation in BC, and elucidation of downstream signalling will provide new insights into the molecular mechanisms of BC oncogenesis.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ビス-トリス, ≥98.0% (titration)
Sigma-Aldrich
抗グリセルアルデヒド-3-リン酸デヒドロゲナーゼ抗体、クローン6C5, clone 6C5, Chemicon®, from mouse
SAFC
ビス-トリス
Sigma-Aldrich
ビス-トリス, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
ビス-トリス, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
Sigma-Aldrich
ビス-トリス, BioXtra, ≥98.0% (titration)
SAFC
ビス-トリス
Sigma-Aldrich
Anti-gapdh antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
MISSION® esiRNA, targeting human FOXM1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Foxm1